Streetbeat News

Products Services

NVAX

Levi & Korsinsky is investigating Novavax, Inc. for potential violations of federal securities laws following the FDA's clinical hold on its combination influenza and Covid-19 shot and stand-alone influenza vaccine.

Portfolio Pulse from

November 15, 2024 | 12:15 am

BMY

Bristol Myers Squibb is facing a $6.7 billion lawsuit for allegedly delaying federal approval of three cancer drugs, impacting former Celgene shareholders. This follows the dismissal of a previous version of the case.

Portfolio Pulse from

November 15, 2024 | 12:00 am

CSX

CSX CEO Joe Hinrichs expressed confidence in the company's ability to adapt to changes in tariffs and manufacturing, emphasizing that as long as the U.S. economy grows, CSX will continue to play a role in transportation.

Portfolio Pulse from

November 15, 2024 | 12:00 am

DSNY

Destiny Media Technologies Inc. has scheduled its fiscal 2024 year-end earnings release and a live webinar for November 21, 2024. The company, known for its Play MPE® music marketing solution, will present its financial results and discuss future prospects.

Portfolio Pulse from

November 14, 2024 | 11:45 pm

AEP

BE

Bloom Energy has signed a significant supply agreement with American Electric Power for up to 1 gigawatt of fuel cells, marking the largest commercial procurement of fuel cells globally. AEP has initially ordered 100 megawatts, with further expansions anticipated in 2025.

Portfolio Pulse from

November 14, 2024 | 11:30 pm

AVCRF

Avricore Health Inc. is shifting its strategic focus towards the UK healthcare market, moving away from its Canadian partnership with Shoppers Drug Mart. This decision aligns with the UCL Partners' rapid cholesterol initiative in London.

Portfolio Pulse from

November 14, 2024 | 11:15 pm

AEP

American Electric Power (AEP) is implementing the largest utility fuel cell initiative in the U.S. by securing up to 1 gigawatt of Bloom Energy solid oxide fuel cells to support data centers and other large energy users.

Portfolio Pulse from

November 14, 2024 | 11:15 pm

MNOV

MediciNova, Inc. has received a Notice of Allowance from the USPTO for a new patent covering MN-001 for decreasing triglyceride synthesis in the liver. This patent is significant for treating conditions like insulin resistance and diabetes, and is expected to expire in 2042.

Portfolio Pulse from

November 14, 2024 | 11:15 pm

AREC

American Resources Corporation (NASDAQ:AREC) is transforming from a metallurgical carbon business to a rare earth and critical mineral refining platform, marking a significant energy transformation.

Portfolio Pulse from

November 14, 2024 | 11:00 pm

PHIO

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported its Q3 2024 financial results and provided a business update. The company is advancing its lead product candidate, PH-762, in a Phase 1b clinical trial following a positive safety recommendation.

Portfolio Pulse from

November 14, 2024 | 11:00 pm